Top

BMC Physiology

Published in:

Open Access 01-12-2017 | Research article

Endothelial dysfunction in the pathogenesis of pre-eclampsia in Ghanaian women

Authors: Kwame Adu-Bonsaffoh, Daniel Ansong Antwi, Ben Gyan, Samuel Amenyi Obed

Published in: BMC Physiology | Issue 1/2017

Abstract

Background

Pre-eclampsia (PE) remains a disease of theories despite extensive research into its etiology. Alteration in the production of vascular endothelial growth factor (VEGF), a biomarker of endothelial dysfunction, is associated with pre-eclampsia although conflicting reports have been reported. The aim of the study was to determine and compare maternal serum levels of VEGF among pre-eclamptics, normotensive non pregnant and pregnant women.

This was a cross-sectional study involving 100 women with pre-eclampsia, 102 women with normotensive pregnancy and 75 normotensives who were not pregnant. The study was carried out at Korle Bu Teaching Hospital (KBTH) from April to June in 2011. Basic socio-demographic and obstetric data were obtained by means of structured questionnaire. Following venesection, about 5mls of blood was sampled from the participants for the various tests. Enzyme Linked Immunosorbent Assay was used to determine the maternal serum levels of free VEGF. Data analysis was performed using SPSS version 20.

Results

Significant reduction in median serum levels of free VEGF was seen in both, normal pregnant [84.06 pg/ml (IQR: 78.90–99.67)] and pre-eclamptic women [4.71 pg/ml, (IQR: 3.41–7.93)] compared to the non-pregnant (395.85 pg/ml, IQR 234.93–625) with p < 0.001; the reduction was far greater in the pre-eclamptic group compared to that of normotensive pregnant group (p < 0.001). Early-onset pre-eclampsia had significantly more severe reduction in free VEGF levels (3.89, IQR: 2.60–5.67 pg/ml) compared to that of late onset PE (5.23, IQR: 3.78–16.97 pg/ml) with p<0.001 indicating a severer endothelial damage in former.

Conclusions

Endothelial dysfunction contributes significantly to the pathogenesis of pre-eclampsia as demonstrated by profound decrease in maternal serum VEGF levels in PE compared to normotensive pregnancy and non-pregnancy state. The pathophysiology of early-onset pre-eclampsia may be partly explained by marked reduction in free serum VEGF levels with resultant severe endothelial dysfunction.

Agarwal I, Karumanchi SA. Pre-eclampsia and the Anti-Angiogenic State. Pregnancy Hypertens. 2011;1(1):17–21.PubMedPubMedCentral

Wang A, Rana S, Karumanchi SA. Pre-eclampsia: The Role of Angiogenic Factors in Its Pathogenesis. Physiology (Bethesda). 2009;24:147–58.CrossRef

American College of Obstetricians and Gynecologists (ACOG). Practice bulletin No.33: Diagnosis and management of preeclampsia and eclampsia. Obstet Gynecol. 2002;99(1):159–67.

Maynard SE, Karumanchi SA. Angiogenic Factors and Pre-eclampsia. Semin Nephrol. 2011;31(1):33–46.CrossRefPubMedPubMedCentral

Lassey AT, Wilson JB. Trends in maternal mortality in Korle Bu Teaching Hospital, 1984–1994. Ghana Med J. 1998;32:910–6.

Tsatsaris V, Goffin F, Munaut C, Franc J¸ Brichant O, Pignon MR, Noel A, Schaaps JP, Cabrol D, Frankenne F, Foidart JM. Overexpression of the Soluble Vascular Endothelial Growth Factor Receptor in Pre-eclamptic Patients: Pathophysiological Consequences. J Clin Endocrinol Metab. 2003;88(11):5555–63.CrossRefPubMed

Maynard SE, Min JY, Merchan J, Lim KH, Li J, Mondal S, Libermann TA, Morgan JP, Sellke FW, Stillman IE, Epstein FH, Sukhatme VP, Karumanchi SA. Excess placental soluble fms like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in pre-eclampsia. J Clin Invest. 2003;111:649–58.CrossRefPubMedPubMedCentral

Eremina V, Sood M, Haigh J, Nagy A, Lajoie G, Ferrara N, Gerber HP, Kikkawa Y, Miner JH, Quaggin SE. Glomerular specific alterations of VEGF-A expression lead to distinct congenital and acquired renal diseases. J Clin Invest. 2003;111:707–16.CrossRefPubMedPubMedCentral

Raymond D, Peterson E. A critical review of early-onset and late-onset pre-eclampsia. Obstet Gynecol Surv. 2011;66(8):497–506.CrossRefPubMed

10.

Tranquilli AL, Brown MA, Zeeman GG, Dekker G, Sibai BM. The definition of severe and early onset pre-eclampsia. Statements from the International Society for the Study of Hypertension in Pregnancy (ISSHP). Pregnancy Hypertens. 2013;3:44–7. doi:10.1016/j.preghy.2012.11.001.PubMed

11.

Adu-Bonsaffoh K, Antwi DA, Obed SA, Gyan B. Nitric oxide dysregulation in the pathogenesis of pre-eclampsia among Ghanaian women. Integr Blood Press Control. 2015;8:1–6.CrossRefPubMedPubMedCentral

12.

Escudero C, Puebla C, Westermeier F, Sobrevia L. Potential cell signaling mechanisms involved in differential placental angiogenesis in mild and severe pre-eclampsia. Curr Vasc Pharmacol. 2009;7:475–85.CrossRefPubMed

13.

Varughese B, Bhatla N, Kumar R, Dwivedi SN, Dhingra R. Circulating angiogenic factors in pregnancies complicated by pre-eclampsia. Natl Med J India. 2010;23(2):77–81.PubMed

14.

Yelumalai S, Muniandy S, Omar SZ, Qvist R. Pregnancy induced hypertension and pre-eclampsia: Levels of angiogenic factors in Malaysian women. J Clin Biochem Nutr. 2010;47(3):191–7.CrossRefPubMedPubMedCentral

15.

Masuyama H, Nakatsukasa H, Takamoto N, Hiramatsu Y. Correlation between Soluble Endoglin, Vascular Endothelial Growth Factor Receptor-1, and Adipocytokines in Pre-eclampsia. J Clin Endocrinol Metab. 2007;92(7):2672–9.CrossRefPubMed

16.

George EM, Granger JP. Recent insights into the pathophysiology of pre-eclampsia. Expert Rev Obstet Gynecol. 2010;5(5):557–66.CrossRefPubMedPubMedCentral

17.

Uzan J, Carbonnel M, Piconne O, Asmar R, Ayoubi JM. Pre-eclampsia: pathophysiology, diagnosis, and management. Vasc Health Risk Manag. 2011;7:467–74.PubMedPubMedCentral

18.

Chaiworapongsa T, Romero R, Espinoza J, Bujold E, Mee Kim Y, Gonclaves LF, Gomez R, Edwin S. Evidence supporting a role for blockade of the vascular endothelial growth factor system in the pathophsiology of pre-eclampsia. Am J Obstet Gynecol. 2004;190:1541–50.CrossRefPubMed

19.

Lygnos MC, Pappa KI, Papadaki HA. Changes in maternal plasma levels of VEGF, bFGF, TGF-beta1, ET-1 and sKL during uncomplicated pregnancy, hypertensive pregnancy and gestational diabetes. In Vivo. 2006;20(1):157–63.PubMed

20.

Sharkey AM, Cooper JC, Balmforth JR, Mclaren J, Clark DE, Charnock-Jones DS, Morris NH, Smith SK. Maternal plasma levels of vascular endothelial growth factor in normotensive pregnancies and in pregnancies complicated by pre-eclampsia. Euro J of Clin Invest. 1996;26:1182–5.CrossRef

21.

Belgore FM, Lip GY, Blann AD. Vascular endothelial growth factor and it receptor, flt-1 in smokers and non-smokers. Br J Biomed Sci. 2000;57:207–13.PubMed

22.

Smith RA, Kenny LC. Current thoughts on the pathogenesis of pre-eclampsia. Obstetrician Gynaecol. 2006;8:7–13.CrossRef

23.

Jelkmann W. Pitfalls in the measurement of circulating vascular endothelial growth factor. Clin Chem. 2001;47(4):617–23.PubMed

Title: Endothelial dysfunction in the pathogenesis of pre-eclampsia in Ghanaian women
Authors: Kwame Adu-Bonsaffoh
Daniel Ansong Antwi
Ben Gyan
Samuel Amenyi Obed
Publication date: 01-12-2017
Publisher: BioMed Central
Published in: BMC Physiology / Issue 1/2017
Electronic ISSN: 1472-6793
DOI: https://doi.org/10.1186/s12899-017-0029-4

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Endothelial dysfunction in the pathogenesis of pre-eclampsia in Ghanaian women

Abstract

Background

Results

Conclusions

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Abstract

Background

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 1/2017

Myocardial susceptibility to ischaemia/reperfusion in obesity: a re-evaluation of the effects of age

Adiponectin is required for maintaining normal body temperature in a cold environment

Androgen receptor is expressed in mouse cardiomyocytes at prenatal and early postnatal developmental stages

Short-term overfeeding of zebrafish with normal or high-fat diet as a model for the development of metabolically healthy versus unhealthy obesity

Disulfide high mobility group box-1 causes bladder pain through bladder Toll-like receptor 4

Variation in branchial expression among insulin-like growth-factor binding proteins (igfbps) during Atlantic salmon smoltification and seawater exposure